Evidence map›Paper›PMID 30275324›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Natural molecules induce and synergize to boost expression of the human antimicrobial peptide β-defensin-3.

Emmanuel Sechet, Erica Telford, Clément Bonamy, Philippe J Sansonetti, Brice Sperandio

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Regulation of Host Defense Peptide Synthesis by Polyphenols.Antibiotics (Basel, Switzerland) · 2023
    Review
  11. MSF Enhances Human Antimicrobial PeptideMolecules (Basel, Switzerland) · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Immunomodulatory and Allergenic Properties of Antimicrobial Peptides.International journal of molecular sciences · 2022
    Review
  16. Review
  17. Advances and perspectives for antimicrobial peptide and combinatory therapies.Frontiers in bioengineering and biotechnology · 2022
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Emmanuel SechetUnité de Pathogénie Microbienne Moléculaire, Institut Pasteur, 75015 Paris, France.
Erica TelfordUnité de Pathogénie Microbienne Moléculaire, Institut Pasteur, 75015 Paris, France.
Clément BonamyUnité de Pathogénie Microbienne Moléculaire, Institut Pasteur, 75015 Paris, France.
Philippe J SansonettiUnité de Pathogénie Microbienne Moléculaire, Institut Pasteur, 75015 Paris, France; philippe.sansonetti@pasteur.fr brice.sperandio@pasteur.fr.
Brice SperandioUnité de Pathogénie Microbienne Moléculaire, Institut Pasteur, 75015 Paris, France; philippe.sansonetti@pasteur.fr brice.sperandio@pasteur.fr.
Inserm · FR

Funding

Howard Hughes Medical Institute
6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) are mucosal defense effectors of the human innate immune response. In the intestine, AMPs are produced and secreted by epithelial cells to protect the host against pathogens and to support homeostasis with commensals. The inducible nature of AMPs suggests that potent inducers could be used to increase their endogenous expression for the prevention or treatment of diseases. Here we aimed at identifying molecules from the natural pharmacopoeia that induce expression of human β-defensin-3 (HBD3), one of the most efficient AMPs, without modifying the production of proinflammatory cytokines. By screening, we identified three molecules isolated from medicinal plants, andrographolide, oridonin, and isoliquiritigenin, which induced HBD3 production in human colonic epithelial cells. This effect was observed without activation of the NF-κB pathway or the expression of associated proinflammatory cytokines. We identified the EGF receptor as the target of these compounds and characterized the downstream-activated MAPK pathways. At the chromatin level, molecules increased phosphorylation of histone H3 on serine S10 and recruitment of the c-Fos, c-Jun, and Elk1 or c-Myc transcription factors at the HBD3 promoter. Interestingly, stimulating cells with a combination of andrographolide and isoliquiritigenin synergistically enhanced HBD3 induction 10-fold more than observed with each molecule alone. Finally, we investigated the molecular basis governing the synergistic effect, confirmed our findings in human colonic primary cells, and demonstrated that synergism increased cellular antimicrobial activity. This work shows the capability of small molecules to achieve induction of epithelial antimicrobial defenses while simultaneously avoiding the deleterious risks of an inflammatory response.

Indexed as

Anti-Infective AgentsAnti-Inflammatory AgentsBacteriabeta-DefensinsBiological ProductsCells, CulturedChalconesColonDiterpenesDiterpenes, KauraneEnzyme InhibitorsEpithelial CellsGene Expression RegulationHumansImmunity, InnateandrographolideAnti-Infective AgentsAnti-Inflammatory Agentsbeta-DefensinsBiological ProductsChalconesDEFB103A protein, humanDiterpenesDiterpenes, KauraneEnzyme Inhibitorsisoliquiritigeninoridoninepithelial cellgene regulationnatural inducersynergistic effectβ-defensin

Identifiers

PMID30275324
PMCPMC6196494
OpenAlexW2894220535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.